Brief: Sprint Bioscience Publishes Study With New Positive Data From Vps34 Program
April 30 (Reuters) - Sprint Bioscience AB SPRINT.ST :
* PUBLISHES SCIENTIFIC STUDY WITH NEW POSITIVE DATA FROM
VPS34
PROGRAM
* RESEARCH RESULTS SHOW THAT SB02024 ACTIVATES IMMUNE SYSTEM
IN
TUMORS IN MALIGNANT MELANOMA AND COLORECTAL CANCER
Source text for Eikon: ID:nWkrc1vpzs
Further company coverage: SPRINT.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Sprint Bioscience AB
See all newsBrief: Sprint Bioscience Q1 Operating Loss SEK 14.3 Mln
Brief: Sprint Bioscience Completes Strategic Evaluation Of STK25 Program
Brief: Sprint Bioscience Appoints Jenni Björnulfson As CFO
Brief: Sprint Bioscience Reports Positive Proof-Of-Concept Results From Program In CKD
Brief: Sprint Bioscience Reports Positive Results From The Vrk1 Program